StemCell Technologies' Contract Services Presents an Educational Webinar on the Use of Hematopoietic Stem Cell Assays in the Detection and Characterization of Chemokine and Cytokine Activity
High content assays for efficient and cost effective evaluation of the potential of compounds to alter or expand hematopoietic stem and progenitor cell populations
Vancouver, BC (January 7, 2007) - Stem Cell Technologies (STI), a world leader in the development of technologies for stem cell biology, is pleased to announce that STI Contract Services (www.contractassay.com) will be providing a free, educational webinar on the detection and characterization of chemokine and cytokine activity using hematopoietic stem and progenitor cell assays.
"Cytokines and Chemokines In Hematopoiesis", will be presented by Dr. Jackie Damen on January 17, 2007 at 11:00 AM PST (2:00 PM EST). Register online by visiting http://www.contractassay.com/webinars.html.
The following topics will be discussed:
- advantages of stem and progenitor cell assays for evaluating the potential of compounds to alter or expand hematopoietic cell populations
- regulation of hematopoietic stem and progenitor cell proliferation and differentiation
- applications of related in vitro and in vivo assays
About Stemcell Technologies Inc. Contract Services
StemCell Technologies is a world leader in the development of products for stem cell biology and has worked to standardize the field through the Global Proficiency Testing Program. Combining StemCell Technologies' industry standard reagents and a scientific team of experts in hematopoiesis and stem cell biology, StemCell Technologies is proud to assist organizations in drug development, agrochemical production, environmental toxicant testing and the research community by offering Contract Services.
